RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,347,357 | +5.3% | 279,115 | +57.2% | 0.02% | +13.3% |
| Q2 2023 | $2,229,441 | +138.5% | 177,503 | +183.7% | 0.02% | +200.0% |
| Q4 2022 | $934,646 | -19.6% | 62,560 | +20.5% | 0.01% | -28.6% |
| Q3 2022 | $1,162,000 | +17.1% | 51,934 | -12.3% | 0.01% | +16.7% |
| Q2 2022 | $992,000 | +91.5% | 59,220 | +242.4% | 0.01% | +50.0% |
| Q1 2022 | $518,000 | +120.4% | 17,298 | +126.3% | 0.00% | +100.0% |
| Q4 2021 | $235,000 | -88.8% | 7,645 | -88.5% | 0.00% | -92.3% |
| Q3 2021 | $2,091,000 | +104.6% | 66,318 | +137.4% | 0.03% | +116.7% |
| Q2 2021 | $1,022,000 | +2.7% | 27,933 | -3.0% | 0.01% | -7.7% |
| Q1 2021 | $995,000 | +45.9% | 28,787 | +75.5% | 0.01% | +44.4% |
| Q4 2020 | $682,000 | +10.4% | 16,400 | +13.0% | 0.01% | 0.0% |
| Q3 2020 | $618,000 | – | 14,519 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |